The Federal Trade Commission has filed a complaint to prevent Edwards Lifesciences Corp. from acquiring JenaValve Technology, Inc., citing concerns regarding the Transcatheter Aortic Valve Replacement - aortic regurgitation market.
- Home
- Posts
- The FTC is contesting the proposed merger between Edwards Lifesciences and JenaValve.
The FTC is contesting the proposed merger between Edwards Lifesciences and JenaValve.
Aug 12, 2025
Keep Reading
No posts found
